Skip to main content

Day: December 10, 2021

The Governance Institute Releases 2021 National Survey of Healthcare Governance

Boards have made small advances in diversity; less time is spent on strategic planning LINCOLN, Neb., Dec. 10, 2021 (GLOBE NEWSWIRE) — U.S. healthcare boards are showing small gains in diversity, but the pandemic has hindered boards’ ability to focus on future direction, according to a new report from The Governance Institute, a service of NRC Health. The Governance Institute’s 2021 survey of U.S. hospitals and health systems, Advancing Governance for a New Future of Healthcare, continues a longitudinal assessment of how board structure, culture, and practices reflect the industry’s movement toward value-based care. The report includes analysis of how systems structure their allocation of responsibilities with their subsidiary boards, how board structure and culture correlate with board practices and overall performance, and how...

Continue reading

ONCAP Completes Sale of Davis-Standard

All amounts in U.S. dollars unless otherwise stated TORONTO, Dec. 10, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that ONCAP has completed the sale of Davis-Standard, LLC (“Davis-Standard”). Davis-Standard is a leading supplier of extrusion and converting systems and related aftermarket products and services for the rigid packaging, flexible packaging and infrastructure end-markets. Of the total proceeds from the sale, Onex’ share was approximately $75 million as a Limited Partner in ONCAP III. Further terms of the transaction are not being disclosed. About ONCAP ONCAP is the mid-market private equity platform of Onex. In partnership with operating company management teams, ONCAP invests in and builds value in North American headquartered small- and medium-sized businesses that are market leaders...

Continue reading

II-VI Incorporated Announces the Closing of $990 Million Notes Offering and Completed Syndication of $4.0 Billion Senior Secured Credit Facilities

PITTSBURGH, Dec. 10, 2021 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI) (the “Company” or “II-VI”) announced today the completion of its previously announced offering of $990 million aggregate principal amount of 5.000% senior notes due 2029 (the “Notes”) in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Act”). The Notes are guaranteed by each of the Company’s domestic subsidiaries that guarantee its existing credit agreement. The Notes are unsubordinated, unsecured obligations of the Company and bear interest at a rate of 5.000% per year. The Company will pay interest on the Notes on December 15 and June 15 of each year, commencing June 15, 2022. The notes will mature on December 15, 2029. The Company also announced today that the lead arrangers for its proposed...

Continue reading

Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

MENLO PARK, Calif. and BOSTON, Dec. 10, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer and other diseases, today announced the closing of its previously announced underwritten public offering of 7,187,500 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 937,500 shares of common stock, at a public offering price of $14.00 per share, less underwriting discounts and commissions. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $100.6 million. All of the shares in the offering are were sold by Adicet. Jefferies and Guggenheim Securities...

Continue reading

CytoDyn to Hold Webcast and Live Q/A on December 14

VANCOUVER, Washington, Dec. 10, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, Nitya Ray, Ph.D., Chief Operating Officer and Chief Technology Officer and Christopher Recknor, M.D., Senior Executive VP of Clinical Operations of CytoDyn will host an investment community webcast on Tuesday, December 14, 2021. CytoDyn will present for 20 minutes, and 40 minutes will be dedicated to live questions and answers.Date: Tuesday, December 14, 2021Time: 1:00 pm ET – 2:00 pm ETAccess: CytoDyn...

Continue reading

ALYI and WPUR Announce Off Grid Electric Vehicle (EV) Charging Solution

Dallas, Texas, Dec. 10, 2021 (GLOBE NEWSWIRE) — Alternet Systems, Inc. (OTC Pink: ALYI) and WaterPure International, Inc. (OTC Pink: WPUR) today announced the companies are partnering on the implementation of an off grid electric vehicle (EV) charging solution to be rolled out in Kenya. Next week, on Thursday, December 16th, the two companies will publish an overview presentation on the off grid electric vehicle charging solution program. ALYI has already started deploying electric motorcycles and electric three-wheel vehicles in East Africa into the taxi and delivery markets as one component of ALYI’s overall EV Ecosystem solution. WPUR has recently refreshed its commitment to delivering water management technologies to the water utilities market and added electric technology innovations for the electric utilities market as an...

Continue reading

Progressive Announces Dividend Information and 2022 Annual Meeting Record Date

MAYFIELD VILLAGE, OHIO, Dec. 10, 2021 (GLOBE NEWSWIRE) — The Board of Directors of The Progressive Corporation (NYSE:PGR) today declared an annual common share dividend, in the amount of $1.50 per share, and a quarterly common share dividend, in the amount of $0.10 per share. The annual common share dividend of $1.50 per share is payable December 29, 2021, to shareholders of record at the close of business on December 20, 2021 (ex-dividend date of December 17, 2021). The 2021 annual dividend amount was determined by the Board based on our capital position, existing capital resources, and expected current and future capital needs. The quarterly common share dividend of $0.10 per share is payable January 14, 2022, to shareholders of record at the close of business on January 7, 2022 (ex-dividend date of January 6, 2022). The Board...

Continue reading

ILUS Announces the Launch of Its Pioneering Maxi A-1 Firefighting Nozzle

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc), announces the launch of the world’s first all-in-one handheld firefighting nozzle with integrated low-pressure water misting capability for electric vehicle fires, flammable gas fires and more NEW YORK, NY, Dec. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ILUS International Inc (OTC: ILUS) is a public safety Mergers and Acquisitions company which is in the process of acquiring and growing global technology companies. The company has already completed 3 acquisitions in 2021 and is in the process of completing a further 4 which it has agreed and signed terms with. Whilst the company is also conducting due diligence on several additional acquisition targets, it is simultaneously focused on the development and improvement of further disruptive technology...

Continue reading

Total number of shares and voting rights at November 30, 2021

10 December 2021 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2021 2, 660, 056,599 1, 350,099 3, 101, 508,888 3, 100, 158,78902/28/2021 2, 660, 056,599 1, 095,099 3, 101, 518,140 3, 100, 423,04103/31/2021 2, 660, 056,599 642,915 3,...

Continue reading

GPOPlus+ CEO Outlines Growth Plan and Provides Update to Investment Community in MoneyTV Interview

GPOX CEO Brett H. Pojunis discussion with MoneyTV Host Donald Baillargeon LAS VEGAS, NV, Dec. 10, 2021 (GLOBE NEWSWIRE) — GPO Plus, Inc. (OTCQB: GPOX), a publicly traded company of diversified industry-specific Group Purchasing Organizations (GPOs), today announced the airing of CEO, Brett H. Pojunis’s, interview on MoneyTV hosted by Executive Producer and anchor, Donald Baillargeon. MoneyTV is accessible in over 200 million households in more than 75 countries. For a complete list of the global TV Listings, syndication, and content partners, please visit; http://moneytv.net/global-tv-listing. Brett’s interview can also be viewed online immediately on GPOPlus+’s website, https://gpox.cc/3ydppMv, or GPOX’s YouTube channel, https://youtu.be/wie1vkKeGwA. During the interview, Brett and Mr. Baillargeon discussed the following topics:the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.